A human challenge model (where volunteers are deliberately infected with a pathogen) may represent the only way to advance hepatitis C vaccine development in the foreseeable future. A foundational hepatitis C challenge study will likely begin in Toronto in 2025. This session discusses the proposed hepatitis C study, participation in a high-impact medical trials more generally, and some of the career paths in academia, government, public health, and medicine that intersect with such research.